CGTX: Cognition Therapeutics Inc
CGTX exchange rate has changed by -2.75% for today. During the day, the instrument was traded at a low of 1.05 and at a high of 1.10.
Follow Cognition Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CGTX News
- Cognition Therapeutics shifts focus to DLB psychosis treatment
- Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
- Cognition’s DLB drug shows positive results in phase 2 trial
- Cognition Therapeutics completes enrollment in expanded access program
- Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
- Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
- Cognition Therapeutics completes enrollment in Alzheimer’s drug trial
- Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?
- Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade
- Cognition’s Alzheimer’s drug trial reaches 75% enrollment milestone
- These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025
- Cognition Therapeutics closes $30 million registered direct offering
- Cognition Therapeutics stock falls after $30 million direct offering
- Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket - AquaBounty Techs (NASDAQ:AQB), Bollinger Innovations (NASDAQ:BINI)
- Cognition Therapeutics regains Nasdaq compliance with $1 share price
- U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.89%
- Cognition Therapeutics stock jumps after FDA confirms Phase 3 design
- Why Sapiens International Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - ProFrac Holding (NASDAQ:ACDC)
- Cognition Therapeutics aligns with FDA on Alzheimer’s drug phase 3 design
- Cognition (CGTX) Q2 Grant Income Jumps
- Cognition Therapeutics' End-Of-Phase 2 Trial Meeting With FDA Could Kick Off Phase 3 Trial For Its Alzheimer's Candidate Zervimesine - Cognition Therapeutics (NASDAQ:CGTX)
- Cognition Therapeutics reports positive results for Alzheimer’s drug
- Cognition Therapeutics stock soars after DLB study results
- Cognition Therapeutics stock rating reiterated at Buy by H.C. Wainwright
Frequently Asked Questions
What is CGTX stock price today?
Cognition Therapeutics Inc stock is priced at 1.06 today. It trades within 1.05 - 1.10, yesterday's close was 1.09, and trading volume reached 698. The live price chart of CGTX shows these updates.
Does Cognition Therapeutics Inc stock pay dividends?
Cognition Therapeutics Inc is currently valued at 1.06. Dividend policy depends on the company, while investors also watch 146.51% and USD. View the chart live to track CGTX movements.
How to buy CGTX stock?
You can buy Cognition Therapeutics Inc shares at the current price of 1.06. Orders are usually placed near 1.06 or 1.36, while 698 and -0.93% show market activity. Follow CGTX updates on the live chart today.
How to invest into CGTX stock?
Investing in Cognition Therapeutics Inc involves considering the yearly range 0.22 - 3.83 and current price 1.06. Many compare -0.93% and -20.30% before placing orders at 1.06 or 1.36. Explore the CGTX price chart live with daily changes.
What are Cognition Therapeutics Inc stock highest prices?
The highest price of Cognition Therapeutics Inc in the past year was 3.83. Within 0.22 - 3.83, the stock fluctuated notably, and comparing with 1.09 helps spot resistance levels. Track Cognition Therapeutics Inc performance using the live chart.
What are Cognition Therapeutics Inc stock lowest prices?
The lowest price of Cognition Therapeutics Inc (CGTX) over the year was 0.22. Comparing it with the current 1.06 and 0.22 - 3.83 shows potential long-term entry points. Watch CGTX moves on the chart live for more details.
When did CGTX stock split?
Cognition Therapeutics Inc has gone through stock splits historically. These changes are visible in , 1.09, and 146.51% after corporate actions.
- Previous Close
- 1.09
- Open
- 1.07
- Bid
- 1.06
- Ask
- 1.36
- Low
- 1.05
- High
- 1.10
- Volume
- 698
- Daily Change
- -2.75%
- Month Change
- -0.93%
- 6 Months Change
- -20.30%
- Year Change
- 146.51%